סימבקסון 10

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

SIMVASTATIN

제공처:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC 코드:

C10AA01

약제 형태:

קפליות

구성:

SIMVASTATIN 10 MG

관리 경로:

פומי

처방전 유형:

מרשם נדרש

Manufactured by:

DEXCEL LTD, ISRAEL

치료 그룹:

SIMVASTATIN

치료 영역:

SIMVASTATIN

치료 징후:

Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia Simvaxon is indicated to: - Reduce the risk of total mortality by reducing coronary death - Reduce the risk of non-fatal myocardial infarction - Reduce the risk for undergoing myocardial revascularization procedures - Reduce the risk of stroke and transient ischemic attacks (TIA's). Hyperlipidemia: Simvaxon is indicated as an adjunct to diet to reduce elevated TOTAL-C LDL-C Apo B and TG and to increase HDL-C in patients with primary hypercholesterolemia ( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simvaxon therefore lowers the LDL-C/HDL-C and the total-C/HDL-C ratios. Homozygous familial hypercholesterolemia: Simvaxon is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. Hype

제품 요약:

Atorvastatin, Cerivastatin, Fluvastatin, Lovastatin, Pravastatin, Simvastatin

승인 날짜:

2020-04-30